HythamAl-MasriMD
Pathology • Tinley Park, ILHematopathology, Anatomic Pathology, Clinical Pathology
Physician
Are you Dr. Al-Masri?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 37 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
8150 185th St Ste A60487
Tinley Park, IL 60487Phone+1 708-444-0444
Summary
- Dr. Hytham Al-Masri, MD is a pathologist in Tinley Park, Illinois. He is currently licensed to practice medicine in Illinois and Michigan.
Education & Training
Loyola University Medical CenterFellowship, Hematopathology, 2003 - 2004
HealthPartners InstituteResidency, Pathology-Anatomic and Clinical, 1996 - 2001
Damascus University Faculty of MedicineClass of 1991
Certifications & Licensure
IL State Medical License 2001 - 2026
MI State Medical License 2003 - 2010
Publications & Presentations
PubMed
- 9 citationsSyncope from dynamic left ventricular outflow tract obstruction simulating hypertrophic cardiomyopathy in a patient with primary AL-type amyloid heart disease.Jose-Luis E Velazquez-Cecena, David L. Lubell, Nagapradeep Nagajothi, Hytham Al-Masri, Mumtaz A. Siddiqui
Texas Heart Institute Journal. 2009-01-01 - 251 citationsAgreement between Programmed Cell Death Ligand-1 Diagnostic Assays across Multiple Protein Expression Cutoffs in Non-Small Cell Lung Cancer.Marianne Ratcliffe, Alan Sharpe, Anita Midha, Craig Barker, Marietta Scott
Clinical Cancer Research. 2017-07-15 - 3 citationsBortezomib induces apoptosis in T-cell prolymphocytic leukemia (T-PLL).Fulya Ozpuyan, Paul N. Meyer, Hongyu Ni, Hytham Al-Masri, Serhan Alkan
Leukemia & Lymphoma. 2007-11-01
Press Mentions
Hematogenix Launches FDA Approved Companion Diagnostic Immuno-Oncology Test for Triple-Negative Breast CancerMarch 13th, 2019
